Home » Newsletters » BioWorld

BioWorld

April 7, 1993

View Archived Issues

CEPHALON COMPLETES SECONDARY

CYTOGEN GETS TWO EUROPEAN PATENTS

ENZON TO CROSS-LICENSE PATENTS WITH ONCOLOGIX

GENTA PULLS OFFERING

THE CANADIAN ROUTE TO GOING PUBLIC

ARMY READY TO GO WITH SINGLE-VACCINE TRIAL

AMERSHAM ACQUISITION FINALIZED

APPLIED IMMUNE SEEKS MARKETING APPROVAL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026